PERMANTIS
LIVE

Serial Number

98269397

Owner

Permantis LLC

Attorney

R. Gwen Peterson

Filing Date

Nov 14, 2023

Add to watchlist:

No watchlists yet
View on USPTO

PERMANTIS Trademark

Serial Number: 98269397

PERMANTIS is a trademark filed by Permantis LLC on November 14, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Permantis LLC

809 Laurel St #70
San Carlos, CA 94070

Entity Type: 16

Trademark Details

Filing Date

November 14, 2023

Registration Date

Not Registered

Published for Opposition

January 7, 2025

Goods & Services

Biological, medical, and pharmaceutical research and development; providing medical and scientific research and medical and scientific information; scientific and medical research and consulting in the field of genomics; scientific and medical research and consulting focused on the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions caused by infectious agents, diseases, disorders and conditions found in neonates and children, and autoimmune, atopic and inflammatory diseases, disorders and conditions; scientific and medical research and consulting focused on the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions relating to pregnancy, women's health, psychiatric issues and psychiatric treatment, cancer and cancer treatment, cardiovascular issues, renal issues, gastrointestinal issues, metabolic issues, issues related to aging, hematological issues, genetic issues, nutritional issues, issues relating to bioterrorism and other man-made threats, and issues relating to poisons and toxins; technical scientific research and medical research services focused on patient-specific nucleic acid sequencing and analysis for the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions caused by infectious agents, diseases, disorders and conditions found in neonates and children, and autoimmune, atopic and inflammatory diseases, disorders and conditions; technical scientific research and medical research services focused on patient-specific nucleic acid sequencing and analysis for the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions relating to pregnancy, women's health, psychiatric issues and psychiatric treatment, cancer and cancer treatment, cardiovascular issues, renal issues, gastrointestinal issues, metabolic issues, issues related to aging, hematological issues, genetic issues, nutritional issues, issues relating to bioterrorism and other man-made threats, and issues relating to poisons and toxins; research, design, development and testing services in the field of diagnostics, biologics and therapeutics for the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions caused by infectious agents, diseases, disorders and conditions found in neonates and children, and autoimmune, atopic and inflammatory diseases, disorders and conditions; research, design, development and testing services in the field of diagnostics, biologics and therapeutics for the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions relating to pregnancy, women's health, psychiatric issues and psychiatric treatment, cancer and cancer treatment, cardiovascular issues, renal issues, gastrointestinal issues, metabolic issues, issues related to aging, hematological issues, genetic issues, nutritional issues, issues relating to bioterrorism and other man-made threats, and issues relating to poisons and toxins; providing laboratory research services in the fields of genomics and the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions caused by infectious agents, diseases, disorders and conditions found in neonates and children, and autoimmune, atopic and inflammatory diseases, disorders and conditions; providing laboratory research services in the fields of genomics and the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions relating to pregnancy, women's health, psychiatric issues and psychiatric treatment, cancer and cancer treatment, cardiovascular issues, renal issues, gastrointestinal issues, metabolic issues, issues related to aging, hematological issues, genetic issues, nutritional issues, issues relating to bioterrorism and other man-made threats, and issues relating to poisons and toxins; providing medical and scientific research information in the fields of genomics and the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions caused by infectious agents, diseases, disorders and conditions found in neonates and children, and autoimmune, atopic and inflammatory diseases, disorders and conditions; providing medical and scientific research information in the fields of genomics and the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions relating to pregnancy, women's health, psychiatric issues and psychiatric treatment, cancer and cancer treatment, cardiovascular issues, renal issues, gastrointestinal issues, metabolic issues, issues related to aging, hematological issues, genetic issues, nutritional issues, issues relating to bioterrorism and other man-made threats, and issues relating to poisons and toxins; compiling of biological and statistical data for research purposes in the field of medical science and medical consultancy; providing clinical scientific laboratory services for others according to laboratory standards regulated by a governmental entity; Medical testing for diagnostic purposes under laboratory standards regulated by a governmental entity; Providing medical and scientific research information, namely, nucleic acid sequencing and analysis services under laboratory standards regulated by a governmental entity

Diagnostic preparations for clinical medical use purposes, namely, the detection, disruption, prevention and treatment of diseases, disorders and conditions; diagnostic preparations and biological reagents for clinical medical purposes, namely, the detection, disruption, prevention and treatment of diseases, disorders and conditions; pharmaceutical preparations for medical use, namely, the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions caused by infectious agents, diseases, disorders and conditions found in neonates and children, and autoimmune, atopic and inflammatory diseases, disorders and conditions; pharmaceutical preparations for medical use, namely, the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions relating to pregnancy, women's health, psychiatric issues and psychiatric treatment, cancer and cancer treatment, cardiovascular issues, renal issues, gastrointestinal issues, metabolic issues, issues related to aging, hematological issues, genetic issues, nutritional issues, issues relating to bioterrorism and other man-made threats, and issues relating to poisons and toxins; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in clinical examination according to laboratory standards regulated by a governmental entity, for the detection of various diseases, disorders and conditions, namely, diseases, disorders and conditions caused by infectious agents, diseases, disorders and conditions found in neonates and children, and autoimmune, atopic and inflammatory diseases, disorders and conditions; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in clinical examination according to laboratory standards regulated by a governmental entity, for the detection of various diseases, disorders and conditions, namely, diseases, disorders and conditions relating to pregnancy, women's health, psychiatric issues and psychiatric treatment, cancer and cancer treatment, cardiovascular issues, renal issues, gastrointestinal issues, metabolic issues, issues related to aging, hematological issues, genetic issues, nutritional issues, issues relating to bioterrorism and other man-made threats, and issues relating to poisons and toxins

Diagnostic preparations for scientific research purposes other than for medical or veterinary purposes; biological preparations for scientific research purposes other than for medical or veterinary use; diagnostic test kits used for providing clinical scientific laboratory services according to laboratory standards regulated by a governmental entity, namely, for the detection of diseases, disorders, and conditions

Licensing of intellectual property rights

Financial asset management and investment management services; financial services, namely, private equity fund investments and funding research awards in the fields of genomics and the detection, disruption, prevention and treatment of diseases, disorders and conditions; capital investment services, namely, investing in technologies focused on the detection, disruption, prevention and treatment of diseases, disorders and conditions; financial services, namely, business fundraising for others; business fundraising for others to support scientific and medical research and procedures; capital investment services

Promoting the services of others, namely, technical and scientific investigation, research and experimentation in the field of genomics; promoting the services of others, namely technical and scientific investigation, research and experimentation in the field of patient-specific nucleic acid sequencing and analysis for the detection, disruption, prevention and treatment of diseases, disorders and conditions

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 14, 2026 EXRA
SOU EXTENSION 2 GRANTED
Feb 5, 2026 EX2G
SOU EXTENSION 2 FILED
Feb 5, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 5, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 1 GRANTED
Aug 31, 2025 EX1G
SOU EXTENSION 1 FILED
Aug 31, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 31, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 4, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 7, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 12, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 10, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 10, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 16, 2024 GNFN
FINAL REFUSAL E-MAILED
Oct 16, 2024 GNFR
FINAL REFUSAL WRITTEN
Oct 16, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 13, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 13, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 20, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 20, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 20, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 20, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 18, 2023 NWOS
NEW APPLICATION ENTERED
Nov 17, 2023 NWAP